Immunologic defects and vaccination in patients with chronic renal failure.
about
Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfateThyroid hormone receptor binding to DNA and T3-dependent transcriptional activation are inhibited by uremic toxinsImmune dysfunction in uremia—an updateHoney in the Prevention and Treatment of Infection in the CKD Population: A Narrative ReviewEffect of daily hemodialysis on monocytes apoptosis.Effects of parathyroid hormone on immune function.Protein-energy wasting and mortality in chronic kidney disease.The risk of infection-related hospitalization with decreased kidney function.Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding.A randomized controlled trial of two schedules of hepatitis B vaccination in predialysed chronic renal failure patientsImproving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvantsChronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis.Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1Sex bias in response to hepatitis B vaccination in end-stage renal disease patients: Meta-analysis.Extensive bleeding during surgical treatment for gingival overgrowth in a patient on haemodialysis--a case report and review of the literature.Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patientsEpidemiology of acute infections among patients with chronic kidney diseaseHemodialysis and hepatitis B vaccination: a challenge to physiciansPeriodontal parameters and BANA test in patients with chronic renal failure undergoing hemodialysisHepatitis B virus infection and related factors in hemodialysis patients in China - systematic review and meta-analysis.Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis.Aberrant function and differentiation of monocytes in end stage renal disease.How safe is renal replacement therapy? A national study of mortality and adverse events contributing to the death of renal replacement therapy recipients.Vaccination issues in patients with chronic kidney disease.Invasive aspergillosis in a patient with end stage renal disease.Effect of vitamin D level on the immunogenicity to hepatitis B vaccination in dialysis patients.Controversial report regarding seroprevalence of hepatitis B and C viruses among hemodialysis patients in kerman province, South-East iran.Pyogenic liver abscess in end-stage renal disease patients: a nationwide longitudinal study.The duration of hepatitis B vaccine immunity in pediatric dialysis patients.Risk of empyema in patients with COPD.
P2860
Q24795302-90E37B0D-F048-467B-89A1-3B2A770CD8F8Q24795393-9076ECBB-707D-40EF-9FF1-4DBBF452EC80Q26829076-CDD299E1-2337-4B37-B0D2-9C81DF601C20Q27692086-1923F885-13E0-43B9-B4F3-342B482A5EEAQ33210504-279E2F63-B002-47A0-9CC8-288398096807Q34155707-54E4877F-EAD1-42E3-8DBB-ADB1D893FA29Q35024794-0ED49132-A624-4259-B28D-0720F99B29C0Q35785324-3E1CFF2E-9796-4C62-8C5F-1973A66279F0Q35939122-D77E1028-6CCD-4E61-BD11-D70D425644E4Q36075066-D2925EF0-AE89-4472-A54E-8DBB522535E8Q36279736-DC8F029B-2595-4A03-8908-2ED0C5C97B6EQ36293944-AB91E6A1-F6E0-4B2E-947B-9ACE646E2D2AQ36379017-9A10939B-3C3A-41E4-B1A2-61B4713374A7Q36447927-C2F58FB8-E5D0-42E8-8A09-F8F29608AD1FQ36611159-5923B493-816A-45AC-92AA-0CEE8EFC7913Q36789845-8E727F19-6AD2-42F7-AEE5-D66136D1CBE7Q37225033-42B39F8F-DE83-4B05-9207-1489EF3B0612Q37568320-35C88A64-D636-45DD-8EB7-7ECC0127A480Q37698176-0B62A723-CA73-4371-A65B-B82A9988E30AQ37800927-3921BBF4-269C-406D-9C4E-6224BAC65312Q38027684-74405268-9073-4D6C-B1CF-CF9FAB6D3484Q38053322-CB8CD28D-ABF3-4036-A850-5C6B6BD55D9DQ38143795-EC0DAB4A-E01D-488B-8664-FA9CF9C2A6DDQ38176987-90063375-9E54-493C-AE1E-18273245B1EFQ40111954-4D359E08-3E36-47F0-BED8-8F2C8216CD8DQ40909907-D3597802-E27B-4024-AFA2-46B3699DB009Q42072650-F68F4273-4805-4CCF-905A-6DA79F9A2039Q42209699-6035FCD8-8D7A-4848-B006-9C4C9FA76CC5Q42217962-E9869989-5B5E-47CA-A19B-523C5751BE3EQ49337339-46E08BD2-E777-4CDD-BC91-ECDB098919B6
P2860
Immunologic defects and vaccination in patients with chronic renal failure.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunologic defects and vaccination in patients with chronic renal failure.
@ast
Immunologic defects and vaccination in patients with chronic renal failure.
@en
Immunologic defects and vaccination in patients with chronic renal failure.
@nl
type
label
Immunologic defects and vaccination in patients with chronic renal failure.
@ast
Immunologic defects and vaccination in patients with chronic renal failure.
@en
Immunologic defects and vaccination in patients with chronic renal failure.
@nl
prefLabel
Immunologic defects and vaccination in patients with chronic renal failure.
@ast
Immunologic defects and vaccination in patients with chronic renal failure.
@en
Immunologic defects and vaccination in patients with chronic renal failure.
@nl
P1476
Immunologic defects and vaccination in patients with chronic renal failure.
@en
P2093
Pesanti EL
P304
P356
10.1016/S0891-5520(05)70174-4
P577
2001-09-01T00:00:00Z